Print

RV 172

A Phase I clinical trial to evaluate the safety and immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Boosted by a Multiclade HIV-1 Recombinant Adenovirus-5 Vector Vaccine, VRC-HIVADV014-00-VP

Trial Details:

I/II Completed
U.S. Military HIV Research Program (MHRP), National Institute of Allergy and Infectious Diseases (NIAID) May 01, 2005
VRC-HIVDNA016-00-VP,VRC-HIVADV014-00-VP
VRC-HIVDNA016-00-VP DNA
VRC-HIVADV014-00-VP Viral Vector - Adeno
Kenya, Tanzania, Uganda 326
NCT00123968
http://clinicaltrials.gov/ct2/show/NCT00123968?term=RV+AND+Vaccine+AND+HIV&rank=2